Country Overview (Pharma & Healthcare)


Publication Single User License (PDF) Price
Canada Pharmaceuticals and Healthcare Report Q2 2015

Canada Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 25 2015
Supported by strong democratic institutions and a long history of stable political Leadership, Canada is home to the second largest pharmaceutical market in the Americas and one of the largest in world. We believe that drugmakers will continue to realise considerable rewards, as sales of patented pharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularly slow penetration of generics.
 
$1,295.00
France Pharmaceuticals and Healthcare Report Q2 2015

France Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 25 2015
France will remain among the largest pharmaceutical markets worldwide in the coming years, especially due to a large and aging population, as well as high per capita spending levels on medicines. However, several cost-containment measures will continue to exert downward pressure on market growth over a multi-year horizon. On the upside, current macroeconomic trends, including low oil and food prices, should be net positive for household consumption in France, posing upside risks to market forecasts in the medium- and long-term.
$1,295.00
Lebanon Pharmaceuticals and Healthcare Report Q2 2015

Lebanon Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 25 2015
Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seeking treatment in the country has sharply risen. Continued political instability will negatively impact government policy regarding healthcare and will in turn put the pharmaceutical sector at risk. However, high per capita spending, an increasing burden of non-communicable diseases along with efforts by the Health Ministry to tackle high levels of corruption within the sector will help sustain market growth in the coming years.
 
$1,295.00
Myanmar Pharmaceuticals and Healthcare Report Q2 2015

Myanmar Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 25 2015
New investment reforms lifting restrictions on the foreign funding of medicine production will make Myanmar an attractive market to international generic drugmakers. This is due to the opportunity of securing a first-mover advantage in this frontier market, as well as being a result of rising medicine consumption. Nonetheless, we highlight that there is significant political uncertainty in Myanmar with the upcoming 2015 elections which poses as a risk to investment.
 
$1,295.00
Romania Pharmaceuticals and Healthcare Report Q2 2015

Romania Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 25 2015
$1,295.00
Slovenia Pharmaceuticals and Healthcare Report Q2 2015

Slovenia Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 25 2015
Our updated forecasts for Slovenia's pharmaceutical and healthcare expenditure indicate a rebound this year from a decline trend that was seen over the past three years. Admittedly, this is true in local currency terms, while the value in USD is expected to take a significant hit, especially in pharmaceutical sales.
 

Headline Expenditure Projections 

$1,295.00
Lithuania Medical Devices Report Q2 2015

Lithuania Medical Devices Report Q2 2015

Date Published: Feb 25 2015
Lithuania's medical device market is returning to growth, having suffered in line with the global economic crisis in 2009 and 2010. The past three years have seen strong growth, and in 2013, the Lithuanian medical device market was valued at an estimated USD257.4mn, or US85 per capita.
 

Headline Industry Forecasts 

$1,295.00
Peru Medical Devices Report Q2 2015

Peru Medical Devices Report Q2 2015

Date Published: Feb 25 2015
Peru represents the second smallest medical device market in the Americas region and has one of the lowest rates of per capita medical device spending in the region, which indicates potential for growth. With a 2013-2018 CAGR projected at around the regional average rate, the market is expected to remain significantly smaller than neighbouring Latin American countries.
 
$1,295.00
2015 Deep Research Report on Global IVIG Industry

2015 Deep Research Report on Global IVIG Industry

Date Published: Feb 23 2015
2015 Deep Research Report on Global IVIG Industry is a professional and depth research report on Global IVIG industry
 
For overview analysis, the report introduces IVIG basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc
 
$3,600.00
Belarus Medical Devices Report Q2 2015

Belarus Medical Devices Report Q2 2015

Date Published: Feb 18 2015
The Belarusian medical device market is under-developed and heavily reliant on imports. Per capita device expenditure is one of the lowest in Europe at USD43. The outlook for the Belarusian medical device market is mixed, with robust growth projected in local currency terms, but due to the depreciation of the Belarusian ruble, the market is forecast to fall in value in US dollar terms. Measured in US dollars, the market is projected to fall at a CAGR of 0.9% over the 2013-2018 period.
 
$1,295.00
Mauritius Pharmaceuticals and Healthcare Report Q1 2015

Mauritius Pharmaceuticals and Healthcare Report Q1 2015

Date Published: Feb 18 2015
With high per-capita pharmaceutical expenditure and a stong governmental interest in pharmaceutical development, combined with a rising demand for non-communicable and chronic disease therapies, Mauritius plays host as an attractive destination for future growth - although the destination still remains relatively untouched on a local level.
 

Headline Expenditure Projections

$1,295.00
Canada Medical Devices Report Q2 2015

Canada Medical Devices Report Q2 2015

Date Published: Feb 18 2015
Canada has a sophisticated and well established medical device market which ranks ninth in the world in terms of value. The market is expected to grow at a CAGR of 4.0% over the 2013-2018 period. This steady growth should see the balance of trade deficit widen owing to Canada's reliance upon imports.
 

Headline Industry Forecasts 

$1,295.00
Mozambique Pharmaceuticals and Healthcare Report Q2 2015

Mozambique Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 18 2015
$1,295.00
France Medical Devices Report Q2 2015

France Medical Devices Report Q2 2015

Date Published: Feb 18 2015
$1,295.00
New Zealand Pharmaceuticals and Healthcare Report Q2 2015

New Zealand Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 18 2015
$1,295.00
Romania Medical Devices Report Q2 2015

Romania Medical Devices Report Q2 2015

Date Published: Feb 18 2015
The Romanian medical device market is projected to grow by a CAGR of 2.9% over the 2013-2018 period, in line with economic growth and rising health expenditure. The scarcity of high-tech equipment and the acute need for renovation within hospitals keeps the demand for medical devices high. The market is expected to remain heavily reliant on imports as the domestic industry mainly produces outdated equipment that can only compete with foreign products in terms of price.
 

Headline Industry Forecasts 

$1,295.00
Peru Pharmaceuticals and Healthcare Report Q2 2015

Peru Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 18 2015
Longstanding trade agreements with the US and EU, along with efficient regulations for quality control will continue to make Peru an appealing destination for drugmakers. However, while the pharmaceutical and healthcare markets continue to grow, the national economy continues to struggle and its dependence on key exports will hamper overall growth in the short-term.
 

Headline Expenditure Projections 

$1,295.00
United Kingdom Medical Devices Report Q2 2015

United Kingdom Medical Devices Report Q2 2015

Date Published: Feb 18 2015
$1,295.00
Poland Pharmaceuticals and Healthcare Report Q2 2015

Poland Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 18 2015
The Polish pharmaceutical market is heavily dependent on public healthcare spending; any negative economic developments will have an impact on the market in the short term. Over the past five years, Poland's economic outperformance has been vital to maintaining positive growth for the private and public healthcare sectors.
 
$1,295.00
Argentina Pharmaceuticals and Healthcare Report Q2 2015

Argentina Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Feb 18 2015
Despite economic activity forecast to continue to decline over the medium-term, Argentina's gradual transition towards more pragmatic and market-friendly economic policies will likely benefit key economic sectors in the long-term, including the pharmaceutical industry. We sustain our view that undervalued local drugmakers could be acquisition targets for foreign firms willing to enhance their footprint in the region as the economy stabilizes.
 
$1,295.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data